Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Zou

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2020
Pyrotinib in <i>HER2</i>-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II StudyCaicun Zhou, Xingya Li, Qiming Wang, et al.
JMIR Medical Informatics|December 18, 2025
A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and ValidationJianjun Zou, Jinyi Huang, Katie Lu, et al.
Diabetes, Obesity & Metabolism|March 26, 2021
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trialJianping Weng, Longyi Zeng, Yuwei Zhang, et al.
Cell Research|July 29, 2020
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trialYi-Zhou Jiang, Yin Liu, Yi Xiao, et al.
BMC Medicine|March 4, 2022
Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trialXiaojian Qin, Dongmei Ji, Weijie Gu, et al.
Journal of Hematology & Oncology|May 13, 2020
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trialFeng Wang, Shukui Qin, Xinchen Sun, et al.
BMC Medical Informatics and Decision Making|July 18, 2025
Machine learning and discriminant analysis model for predicting benign and malignant pulmonary nodulesZhi Li, Wenjing Zhang, Jinyi Huang, et al.
Frontiers in Neurology|November 19, 2019
Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke EtiologyChao Sun, Xiang Li, Zheng Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2019
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical TrialQiao Li, Xiuwen Guan, Shanshan Chen, et al.
Diabetes, Obesity & Metabolism|January 8, 2021
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trialJuming Lu, Liujun Fu, Yan Li, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2020
Pyrotinib in <i>HER2</i>-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II StudyCaicun Zhou, Xingya Li, Qiming Wang, et al.
JMIR Medical Informatics|December 18, 2025
A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and ValidationJianjun Zou, Jinyi Huang, Katie Lu, et al.
Diabetes, Obesity & Metabolism|March 26, 2021
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trialJianping Weng, Longyi Zeng, Yuwei Zhang, et al.
Cell Research|July 29, 2020
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trialYi-Zhou Jiang, Yin Liu, Yi Xiao, et al.
BMC Medicine|March 4, 2022
Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trialXiaojian Qin, Dongmei Ji, Weijie Gu, et al.
Journal of Hematology & Oncology|May 13, 2020
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trialFeng Wang, Shukui Qin, Xinchen Sun, et al.
BMC Medical Informatics and Decision Making|July 18, 2025
Machine learning and discriminant analysis model for predicting benign and malignant pulmonary nodulesZhi Li, Wenjing Zhang, Jinyi Huang, et al.
Frontiers in Neurology|November 19, 2019
Safety and Efficacy of Tirofiban Combined With Mechanical Thrombectomy Depend on Ischemic Stroke EtiologyChao Sun, Xiang Li, Zheng Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2019
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical TrialQiao Li, Xiuwen Guan, Shanshan Chen, et al.
Diabetes, Obesity & Metabolism|January 8, 2021
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trialJuming Lu, Liujun Fu, Yan Li, et al.
Pageof 20